Baxter ROE 2006-2019 | BAX

Current and historical return on equity (ROE) values for Baxter (BAX) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Baxter ROE for the three months ending June 30, 2019 was 21.21%.
Baxter ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2019-06-30 $1.58B $7.84B 19.51%
2019-03-31 $1.58B $7.67B 18.91%
2018-12-31 $1.62B $7.82B 18.62%
2018-09-30 $1.21B $9.11B 13.32%
2018-06-30 $0.91B $8.87B 9.98%
2018-03-31 $0.83B $9.09B 9.06%
2017-12-31 $0.72B $9.12B 7.88%
2017-09-30 $1.03B $9.46B 11.59%
2017-06-30 $0.91B $9.17B 10.46%
2017-03-31 $1.86B $8.68B 21.76%
2016-12-31 $4.97B $8.28B 57.61%
2016-09-30 $4.93B $8.66B 56.21%
2016-06-30 $4.80B $8.51B 56.05%
2016-03-31 $3.92B $9.02B 46.43%
2015-12-31 $0.97B $8.87B 12.09%
2015-09-30 $1.72B $7.85B 21.92%
2015-06-30 $2.18B $8.02B 27.38%
2015-03-31 $2.37B $7.29B 29.13%
2014-12-31 $2.50B $8.16B 29.41%
2014-09-30 $1.87B $8.43B 21.81%
2014-06-30 $1.95B $8.69B 23.16%
2014-03-31 $2.02B $8.69B 25.01%
2013-12-31 $2.01B $8.49B 26.35%
2013-09-30 $2.18B $7.75B 30.03%
2013-06-30 $2.22B $7.32B 31.16%
2013-03-31 $2.29B $7.00B 32.97%
2012-12-31 $2.33B $6.98B 33.54%
2012-09-30 $2.30B $7.19B 33.27%
2012-06-30 $2.29B $6.61B 33.17%
2012-03-31 $2.24B $6.96B 31.77%
2011-12-31 $2.22B $6.83B 31.51%
2011-09-30 $2.18B $7.19B 30.98%
2011-06-30 $2.13B $7.24B 30.72%
2011-03-31 $2.05B $6.97B 30.80%
2010-12-31 $1.42B $6.80B 21.55%
2010-09-30 $1.57B $6.76B 23.27%
2010-06-30 $1.57B $6.13B 22.87%
2010-03-31 $1.63B $6.66B 23.09%
2009-12-31 $2.21B $7.42B 31.88%
2009-09-30 $2.20B $7.31B 33.20%
2009-06-30 $2.14B $6.77B 32.63%
2009-03-31 $2.10B $6.16B 31.44%
2008-12-31 $2.01B $6.29B 29.22%
2008-09-30 $1.92B $7.06B 27.29%
2008-06-30 $1.85B $7.22B 26.93%
2008-03-31 $1.73B $7.00B 25.78%
2007-12-31 $1.71B $6.92B 25.77%
2007-09-30 $1.66B $6.29B 25.70%
2007-06-30 $1.64B $6.69B 25.33%
2007-03-31 $1.52B $6.60B 24.21%
2006-12-31 $1.40B $6.27B 23.07%
2006-09-30 $1.26B $6.34B 22.60%
2006-06-30 $1.00B $5.87B 19.70%
2006-03-31 $1.01B $5.75B 21.73%
2005-12-31 $0.96B $4.30B 22.63%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $43.795B $11.127B
Baxter International Inc., through its subsidiaries, develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma and other chronic and acute medical conditions. As a global, diversified healthcare company, Baxter applies a unique combination of expertise in medical devices, pharmaceuticals and biotechnology to create products that advance patient care worldwide. Baxter India is a wholly owned subsidiary of Baxter International Inc. Baxter India believes in engaging collaboratively with patients, healthcare providers, governments and non - government organizations to help change the lives of millions of people by providing safe, effective and affordable products and therapies.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $148.355B 27.89
Medtronic (MDT) Ireland $136.463B 19.49
Stryker (SYK) United States $80.545B 27.85
Boston Scientific (BSX) United States $58.324B 28.29
EssilorLuxottica Societe Anonyme (ESLOY) France $30.720B 0.00
Zimmer Biomet Holdings (ZBH) United States $27.744B 17.76
Coloplast (CLPBY) Denmark $26.309B 42.00
Lonza Group Ag (LZAGY) Switzerland $25.750B 0.00
Terumo (TRUMY) Japan $23.727B 27.28
Smith & Nephew SNATS (SNN) United Kingdom $19.987B 0.00
ResMed (RMD) United States $19.012B 36.26
Sunny Optical Technology (SNPTF) China $13.031B 0.00
Bio-Rad Laboratories (BIO) United States $9.510B 50.98
Canopy Growth (CGC) Canada $9.478B 0.00
Insulet (PODD) United States $9.126B 540.75
William Demant Holdings (WILYY) Denmark $7.136B 0.00
Hill-Rom Holdings (HRC) United States $7.016B 20.92
Haemonetics (HAE) United States $6.910B 52.15
Perrigo (PRGO) Ireland $6.214B 11.45
GN STORE NORD (GNNDY) Denmark $5.897B 30.11
Aurora Cannabis (ACB) Canada $5.769B 56.70
GW Pharmaceuticals (GWPH) United Kingdom $4.612B 0.00
Shandong Weigao Medical Polymer (SHWGF) China $4.296B 0.00
Neogen (NEOG) United States $3.587B 59.66
ICU Medical (ICUI) United States $3.452B 22.39
NuVasive (NUVA) United States $3.286B 26.19
Hutchison China MediTech (HCM) China $2.661B 0.00
Quidel (QDEL) United States $2.508B 24.91
Agios Pharmaceuticals (AGIO) United States $2.497B 0.00
National Vision Holdings (EYE) United States $2.260B 48.78
Cardiovascular Systems (CSII) United States $1.637B 0.00
Aphria (APHA) $1.496B 0.00
Phibro Animal Health (PAHC) United States $1.215B 18.20
AtriCure (ATRC) United States $1.045B 0.00
VAREX IMAGING (VREX) United States $0.981B 22.60
NanoString Technologies (NSTG) United States $0.942B 0.00
Omeros (OMER) United States $0.916B 0.00
PetIQ (PETQ) United States $0.862B 20.36
Lantheus Holdings (LNTH) United States $0.850B 22.34
Eagle Pharmaceuticals (EGRX) United States $0.772B 19.67
Cerus (CERS) United States $0.731B 0.00
MacroGenics (MGNX) United States $0.708B 0.00
Quanterix (QTRX) United States $0.655B 0.00
TG Therapeutics (TGTX) United States $0.621B 0.00
LeMaitre Vascular (LMAT) United States $0.615B 36.47
Surmodics (SRDX) United States $0.597B 113.41
OraSure Technologies (OSUR) United States $0.441B 20.40
Meridian Bioscience (VIVO) United States $0.427B 13.33
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.413B 0.00
BioLife Solutions (BLFS) United States $0.361B 118.69
United Health Products (UEEC) United States $0.357B 0.00
Utah Medical Products (UTMD) United States $0.356B 26.05
Zynex (ZYXI) United States $0.319B 33.86
Owens & Minor (OMI) United States $0.304B 9.11
Vapotherm (VAPO) United States $0.251B 0.00
Bovie Medical (APYX) United States $0.248B 0.00
Chimerix (CMRX) United States $0.156B 0.00
Cytosorbents (CTSO) United States $0.154B 0.00
Rockwell Medical (RMTI) United States $0.153B 0.00
Fonar (FONR) United States $0.151B 7.97
Female Health (VERU) United States $0.126B 0.00
Chembio Diagnostics (CEMI) United States $0.096B 0.00
United-Guardian (UG) United States $0.087B 20.55
Surface Oncology (SURF) United States $0.057B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.056B 0.00
Nephros (NEPH) United States $0.054B 0.00
Trinity Biotech (TRIB) Ireland $0.045B 15.58
ImmuCell (ICCC) United States $0.042B 0.00
Senestech (SNES) United States $0.035B 0.00
Valeritas Holdings (VLRX) United States $0.013B 0.00
Capricor Therapeutics (CAPR) United States $0.011B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.010B 0.00
GUARDION HEALTH (GHSI) United States $0.006B 0.00
Akers Biosciences Inc (AKER) United States $0.006B 0.00
NeuroMetrix (NURO) United States $0.003B 0.00